Downregulation of MGMT expression by targeted editing of DNA methylation enhances temozolomide sensitivity in glioblastoma

Glioblastoma is the most common and aggressive primary tumor of the central nervous system with poor outcome. Current gold standard treatment is surgical resection followed by a combination of radio- and chemotherapy. Efficacy of temozolomide (TMZ), the primary chemotherapeutic agent, depends on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xinyu, Abdallah, Mohammed O.E., Breuer, Peter, Stahl, Fabian, Bakhit, Yousuf, Potthoff, Anna-Laura, Pregler, Barbara E.F., Schneider, Matthias, Waha, Andreas, Wüllner, Ullrich, Evert, Bernd O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475512/
https://www.ncbi.nlm.nih.gov/pubmed/37634280
http://dx.doi.org/10.1016/j.neo.2023.100929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475512/
https://www.ncbi.nlm.nih.gov/pubmed/37634280
http://dx.doi.org/10.1016/j.neo.2023.100929

Ejemplares similares